Trials / Recruiting
RecruitingNCT05397392
Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Nanjing First Hospital, Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes
Detailed description
Cardiorenal syndrome is a clinical syndrome caused by acute or chronic injury of one of the heart and kidney resulting to acute or chronic dysfunction of the other organ. In recent years, the morbidity of cardiorenal syndrome has increased rapidly in China. Its condition is complex and difficult to treat. Due to the lack of studies specifically targeting the cardiorenal syndrome population, there is no systematic in-depth understanding of the pathogenesis and risk factors of this kind of disease. In clinic, the course of various types of cardiorenal syndrome is complex and difficult to be summarized into a specific type. Therefore, we intend to conduct a clinical systematic observation and research on such patients so as to optimize a more reasonable treatment scheme.
Conditions
- Heart Failure
- Kidney Diseases
- Kidney Injury
- Heart Valve Diseases
- Dialysis; Complications
- Coronary Heart Disease
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | guideline recommended routine treatment |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2026-12-01
- Completion
- 2027-12-01
- First posted
- 2022-05-31
- Last updated
- 2022-06-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05397392. Inclusion in this directory is not an endorsement.